Skip to main content Help with accessibility Skip to main navigation

TAPENTADOL prolonged release tablets (Palexia® SR)

CCG Approval Status:

Date Added: 27 - Jun - 2018
Body System:
Amber initiated

The Pan Mersey Area Prescribing Committee recommends TAPENTADOL prolonged release tablets (Palexia® SR) for severe chronic pain in adults only when initiated by chronic pain specialists or palliative care specialists.